Nucleic Acid Based Gene Therapy Global Market Report 2024

Request Free Sample Buy Report

Global Nucleic Acid Based Gene Therapy Market Report 2024

Nucleic Acid Based Gene Therapy Global Market Report 2024 – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 250 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request Sample

Request For Discount

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Nucleic Acid Based Gene Therapy Market Definition And Segments

Gene therapy is used for correcting defective genes that are responsible for disease development. Nucleic acid-based therapeutics is used to treat genetic disorders and diseases for which there exists no permanent cure, such as anemia, sickle cell, cystic fibrosis, and thalassemia.

The main technologies in nucleic acid-based gene therapy are anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogues, ribozymes, aptamers, and others. The nucleoside analogues are a significant class of antiviral agents that are generally utilized in the therapy of human immunodeficiency virus (HIV) infection, hepatitis B virus (HBV), hepatitis C virus (HCV), and cytomegalovirus (CMV). The various applications include oncology, muscular dystrophy, muscular disorders, and rare diseases that are used by end-users such as hospitals and clinics and academic and research institutes.

The nucleic acid based gene therapy market covered in this report is segmented –

1) By Technology: Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies

2) By Application: Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases

3) By End User: Hospitals And Clinics, Academic And Research Institutes

The nucleic acid based gene therapy market size has grown strongly in recent years. It will grow from $0.75 billion in 2023 to $0.82 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to growing understanding of human genetics, growing demand for personalized medicine, expanding pipeline of gene therapy products, growing government support for gene therapy, genetic disorders, cancer therapy.

The nucleic acid based gene therapy market size is expected to see rapid growth in the next few years. It will grow to $1.2 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to expanding indications, increased funding, patient advocacy and awareness, growing investment in gene therapy research and development, expanding scope of gene therapy applications, rare diseases. Major trends in the forecast period include ex vivo gene editing, advances in in vivo gene editing, combination therapies, targeted delivery systems, gene editing for rare diseases, non-viral vectors.

Government And Industry Backing Fueling The Surge In Nucleic Acid-Based Gene Therapy Demand

Rising financial support by the government and the companies is projected to drive the demand for nucleic acid-based gene therapy. Nucleic acid therapeutics are analogs of naturally occurring acids or proteins responsible for genetic expression. The traditional therapies do not have any cure for the treatment of diseases such as cystic fibrosis, hemophilia, sickle cell anemia, thalassemia, and diabetes. Genetic profiling and molecular target identification form the backbone of these classes of drugs. Nucleic acid medication has greater potential for the treatment of these diseases, as they target the genetic basis of diseases and have a permanent cure. Rising financial support by the government and the companies dealing in the market for gene therapy is expected to contribute to increasing the demand for nucleic acid-based gene therapy market. For instance, in August 2022, National Institute of Health (NIH) announced investment of $34 million annually for upcoming 5 years to develop HIV treatment research. The government support for gene therapies will contribute to the growth of the nucleic acid based gene therapy market.

Healthcare Expenditure's Impact Driving The Nucleic Acid Based Gene Therapy Market

The rising healthcare expenditure is anticipated to drive the expansion of the nucleic acid gene therapy market in the future. Healthcare expenditure refers to spending on healthcare costs and represents the total amount of money spent on healthcare-related goods and services within a given healthcare system or economy. Healthcare expenditure plays a crucial role in supporting the development, accessibility, and for nucleic acid gene therapy. For instance, in November 2022, according to the Canadian Institute for Health Information, a US-based not-for-profit organization, healthcare expenditure rose to 0.8%, which is $331 billion in 2022, and it was 7.6% in 2021. Therefore, rising healthcare expenditure is driving the growth of the nucleic acid gene therapy market.

Major companies operating in the nucleic acid based gene therapy market include Celsion Corporation, Wave Life Sciences, Imugene Ltd., Caperna LLC, Phylogica Limited, Protagonist Therapeutics Inc., Benitec Biopharma Ltd., EGEN, BioMedica, Transgene SA, Copernicus Therapeutics Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., Beam Therapeutics Inc., BioNTech SE, Bluebird Bio Inc., CRISPR Therapeutics AG, Editas Medicine Inc., Genevant Sciences Inc., Homology Medicines Inc., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., MaxCyte Inc., Moderna Inc., Novartis International AG, Orchard Therapeutics PLC, Precision BioSciences Inc., REGENXBIO Inc.

Regulatory Hurdles And Cost Implications A Challenge To Nucleic Acid-Based Gene Therapy Demand

Stringent regulations imposed on gene therapies raise the price of gene therapies, which in turn hinders the demand for nucleic acid-based gene therapies. The excessive regulatory oversights create an expensive and elongated route for approval increasing the expenses. According to Foundation for Economic Education (FEE), unlike other drugs approved or regulated by the Food and Drug Administration (FDA), gene therapies are not only subject to the regulatory structure of the FDA, but also the Recombinant DNA Advisory Committee and Office of Biotechnology Activities. Also, as estimated by FEE, an approved gene therapy drug costs nearly $5.0 billion, which is five times higher than that of the average cost of FDA approval. The high cost of gene therapeutics drugs places them beyond the financial reach of the populace. This scenario is anticipated to restrain the market growth of the nucleic acid-based gene therapy market.

Innovative Drug Development Pioneering Advancements In The Nucleic Acid Drugs Market

Major companies operating in the nucleic acid drugs market are developing innovative drugs such as Casimersen to drive revenues in the market. Casimersen is an ASO indicated for the treatment of DMD in patients with a confirmed mutation amenable to exon 45 skipping. For instance, in February 2021, Sarepta Therapeutics Inc., a US-based biotechnology company launched Casimersen (Amondys 45) approved by the Food and Drug Administration, a US-based government agency. This indication is based on a statistically significant increase in dystrophin production in skeletal muscle observed in patients treated with AMONDYS 45, and predicted a clinical benefit for those patients who are exon 45 amenable.

Strategic Collaborations And Partnerships Driving Production Excellence In The Nucleic Acid-Based Gene Therapy Market

The companies in the nucleic acid based gene therapy market are focusing on strategic partnerships and collaborations to help boost production. Major players are entering into partnership to expand their market and leverage each other’s resources. For example, in January 2022, Pfizer Inc., an American multinational pharmaceutical and biotechnology corporation, and Beam Therapeutics Inc., an American biotechnology company developing precision genetic medicines through base editing, announced an exclusive four-year research collaboration focused on in vivo base editing programs for three targets for rare genetic diseases of the liver, muscle and central nervous system. Similarly, in August 2022, Merck, an American multinational pharmaceutical company, and Orna Therapeutics, a US based biotechnology company pioneering a new investigational class of engineered circular RNA (oRNA) therapies, announced a collaboration agreement to discover, develop, and commercialize multiple programs, including vaccines and therapeutics in the areas of infectious disease and oncology.

North America was the largest region in the nucleic acid-based gene therapy market in 2023. Western Europe was the second-largest region in the nucleic acid-based gene therapy market report. The regions covered in the nucleic acid based gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the nucleic acid based gene therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The nucleic acid based gene therapy market consists of sales of nucleic acid based gene therapy technologies such as anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers, and other technologies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The nucleic acid-based gene therapy market research report is one of a series of new reports from The Business Research Company that provides nucleic acid-based gene therapy market statistics, including nucleic acid-based gene therapy industry global market size, regional shares, competitors with a nucleic acid-based gene therapy market share, detailed nucleic acid-based gene therapy market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid-based gene therapy industry. This nucleic acid-based gene therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Nucleic Acid Based Gene Therapy Market Report Scope

Report Attribute	Details
Market Size Value In 2024	$0.82 billion
Revenue Forecast In 2033	$1.2 billion
Growth Rate	CAGR of 10.1% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Technology: Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies 2) By Application: Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases 3) By End User: Hospitals And Clinics, Academic And Research Institutes
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled	Celsion Corporation; Wave Life Sciences; Imugene Ltd.; Caperna LLC; Phylogica Limited; Protagonist Therapeutics Inc.; Benitec Biopharma Ltd.; EGEN; BioMedica; Transgene SA; Copernicus Therapeutics Inc.; 4D Molecular Therapeutics Inc.; Abeona Therapeutics Inc.; Alnylam Pharmaceuticals Inc.; Amgen Inc.; Beam Therapeutics Inc.; BioNTech SE; Bluebird Bio Inc.; CRISPR Therapeutics AG; Editas Medicine Inc.; Genevant Sciences Inc.; Homology Medicines Inc.; Intellia Therapeutics Inc.; Ionis Pharmaceuticals Inc.; MaxCyte Inc.; Moderna Inc.; Novartis International AG; Orchard Therapeutics plc; Precision BioSciences Inc.; REGENXBIO Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

Table Of Contents

1. Executive Summary

2. Nucleic Acid Based Gene Therapy Market Characteristics

3. Nucleic Acid Based Gene Therapy Market Trends And Strategies

4. Nucleic Acid Based Gene Therapy Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market

4.2. Ukraine-Russia War Impact On the Market

4.3. COVID-19 Impact On the Market

5. Global Nucleic Acid Based Gene Therapy Market Size and Growth

5.1. Global Nucleic Acid Based Gene Therapy Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Nucleic Acid Based Gene Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Nucleic Acid Based Gene Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Nucleic Acid Based Gene Therapy Market Segmentation

6.1. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Anti-Sence and Anti-Gene

Short Inhibitory Sequences

Gene Transfer Therapy

Nucleoside Analogs

Ribozymes

Aptamers

Other Technologies

6.2. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Oncology

Muscular Dystrophy/ Muscular Disorders

Rare Diseases

6.3. Global Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals And Clinics

Academic And Research Institutes

7. Nucleic Acid Based Gene Therapy Market Regional And Country Analysis

7.1. Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Nucleic Acid Based Gene Therapy Market

8.1. Asia-Pacific Nucleic Acid Based Gene Therapy Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Nucleic Acid Based Gene Therapy Market

9.1. China Nucleic Acid Based Gene Therapy Market Overview

9.2. China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Nucleic Acid Based Gene Therapy Market

10.1. India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Nucleic Acid Based Gene Therapy Market

11.1. Japan Nucleic Acid Based Gene Therapy Market Overview

11.2. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Nucleic Acid Based Gene Therapy Market

12.1. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Nucleic Acid Based Gene Therapy Market

13.1. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Nucleic Acid Based Gene Therapy Market

14.1. South Korea Nucleic Acid Based Gene Therapy Market Overview

14.2. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Nucleic Acid Based Gene Therapy Market

15.1. Western Europe Nucleic Acid Based Gene Therapy Market Overview

15.2. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Nucleic Acid Based Gene Therapy Market

16.1. UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Nucleic Acid Based Gene Therapy Market

17.1. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Nucleic Acid Based Gene Therapy Market

18.5. France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Nucleic Acid Based Gene Therapy Market

19.9. Italy Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Nucleic Acid Based Gene Therapy Market

20.13. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Nucleic Acid Based Gene Therapy Market

21.1. Eastern Europe Nucleic Acid Based Gene Therapy Market Overview

21.2. Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Nucleic Acid Based Gene Therapy Market

22.1. Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Nucleic Acid Based Gene Therapy Market

23.1. North America Nucleic Acid Based Gene Therapy Market Overview

23.2. North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Nucleic Acid Based Gene Therapy Market

24.1. USA Nucleic Acid Based Gene Therapy Market Overview

24.2. USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Nucleic Acid Based Gene Therapy Market

25.1. Canada Nucleic Acid Based Gene Therapy Market Overview

25.2. Canada Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Nucleic Acid Based Gene Therapy Market

26.1. South America Nucleic Acid Based Gene Therapy Market Overview

26.2. South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Nucleic Acid Based Gene Therapy Market

27.1. Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Nucleic Acid Based Gene Therapy Market

28.1. Middle East Nucleic Acid Based Gene Therapy Market Overview

28.2. Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Nucleic Acid Based Gene Therapy Market

29.1. Africa Nucleic Acid Based Gene Therapy Market Overview

29.2. Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Nucleic Acid Based Gene Therapy Market Competitive Landscape And Company Profiles

30.1. Nucleic Acid Based Gene Therapy Market Competitive Landscape

30.2. Nucleic Acid Based Gene Therapy Market Company Profiles

30.2.1. Celsion Corporation

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Wave Life Sciences

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Imugene Ltd.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Caperna LLC

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Phylogica Limited

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Global Nucleic Acid Based Gene Therapy Market Competitive Benchmarking

32. Global Nucleic Acid Based Gene Therapy Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Nucleic Acid Based Gene Therapy Market

34. Nucleic Acid Based Gene Therapy Market Future Outlook and Potential Analysis

34.1 Nucleic Acid Based Gene Therapy Market In 2028 - Countries Offering Most New Opportunities

34.2 Nucleic Acid Based Gene Therapy Market In 2028 - Segments Offering Most New Opportunities

34.3 Nucleic Acid Based Gene Therapy Market In 2028 - Growth Strategies

34.3.1 Market Trend Based Strategies

34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations

35.2. Currencies

35.3. Historic And Forecast Inflation Rates

35.4. Research Inquiries

35.5. The Business Research Company

35.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Celsion Corporation Financial Performance

Table 75: Wave Life Sciences Financial Performance

Table 76: Imugene Ltd. Financial Performance

Table 77: Caperna LLC Financial Performance

Table 78: Phylogica Limited Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Celsion Corporation Financial Performance

Figure 75: Wave Life Sciences Financial Performance

Figure 76: Imugene Ltd. Financial Performance

Figure 77: Caperna LLC Financial Performance

Figure 78: Phylogica Limited Financial Performance

Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies

Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company

What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?

How Will The Laryngoscope Market Grow In 2022?

The Business Research Company offers the neuroscience antibodies and assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the narcotics scanner market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the aircraft doors market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the aircraft landing gear market research report 2022 with industry size, share, segments and market growth

Gene Therapy Global Market Report 2024 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gene Editing Global Market Report 2024 – By Technology (CRISPR, TALEN, ZFN), By Application (Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering), By End Users (Biotechnology, Pharmaceutical, Contract Research Organization) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Next Generation Sequencing Global Market Report 2024 – By Product (Instruments, Reagents And Kits, Software), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies), By Application (Diagnostics, Drug Discovery, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Molecular Diagnostics Devices And Equipment Global Market Report 2024 – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA (Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies), By Application (Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications), By End User (Diagnostic laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

NGS-Based RNA-Sequencing Global Market Report 2024 – By Product And Service (Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing), By Application (Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), By End User (Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Genetic Testing Global Market Report 2024 – By Type (Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing, Other Types), By Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing), By Application (Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Other Applications), By End User (Hospitals And Clinics, Diagnostic Laboratories And Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Point-Of-Care Molecular Diagnostics Global Market Report 2024 – By Product And Service (Assays And Kits, Instruments And Analyzers, Software And Services), By Technology (Reverse Transcription - Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing), By Application (Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology), By End-User (Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Medical Equipment Global Market Report 2024 – By Type (In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices), By Type Of Expenditure (Public, Private), By Product (Instruments And Equipment, Disposables And Consumables), By End User (Hospitals And Clinics, Homecare And Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the nucleic acid based gene therapy market?

How will the nucleic acid based gene therapy market drivers and restraints affect the nucleic acid based gene therapy market dynamics? What forces will shape the nucleic acid based gene therapy industry going forward?

The nucleic acid based gene therapy market major growth driver - government and industry backing fueling the surge in nucleic acid-based gene therapy demand. For further insights on the nucleic acid based gene therapy market, request a sample here

What is the forecast market size or the forecast market value of the nucleic acid based gene therapy market ?

The nucleic acid based gene therapy market size has grown strongly in recent years. It will grow from $0.75 billion in 2023 to $0.82 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to growing understanding of human genetics, growing demand for personalized medicine, expanding pipeline of gene therapy products, growing government support for gene therapy, genetic disorders, cancer therapy. The nucleic acid based gene therapy market size is expected to see rapid growth in the next few years. It will grow to $1.2 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to expanding indications, increased funding, patient advocacy and awareness, growing investment in gene therapy research and development, expanding scope of gene therapy applications, rare diseases. Major trends in the forecast period include ex vivo gene editing, advances in in vivo gene editing, combination therapies, targeted delivery systems, gene editing for rare diseases, non-viral vectors. For further insights on the nucleic acid based gene therapy market, request a sample here

How is the nucleic acid based gene therapy market segmented?

The nucleic acid based gene therapy market is segmented
1) By Technology: Anti-Sence and Anti-Gene; Short Inhibitory Sequences; Gene Transfer Therapy; Nucleoside Analogs; Ribozymes; Aptamers; Other Technologies
2) By Application: Oncology; Muscular Dystrophy/ Muscular Disorders; Rare Diseases
3) By End User: Hospitals And Clinics; Academic And Research InstitutesFor further insights on the nucleic acid based gene therapy market, request a sample here

Which region has the largest share of the nucleic acid based gene therapy market? What are the other regions covered in the report?

North America was the largest region in the nucleic acid-based gene therapy market in 2023. Western Europe was the second-largest region in the nucleic acid-based gene therapy market report. The regions covered in the nucleic acid based gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. For further insights on the nucleic acid based gene therapy market, request a sample here.

Who are the major players in the nucleic acid based gene therapy market?

What are the key trends in the nucleic acid based gene therapy market?

Major trend in the nucleic acid based gene therapy market - innovative drug development pioneering advancements in the nucleic acid drugs market. For further insights on the nucleic acid based gene therapy market, request a sample here.

What are the major opportunities in the nucleic acid based gene therapy market? What are the strategies for the nucleic acid based gene therapy market?

For detailed insights on the major opportunities and strategies in the nucleic acid based gene therapy market, request a sample here.

How does the nucleic acid based gene therapy market relate to the overall economy and other similar markets?

For detailed insights on nucleic acid based gene therapy market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the nucleic acid based gene therapy industry?

For detailed insights on the mergers and acquisitions in the nucleic acid based gene therapy industry, request a sample here.

What are the key dynamics influencing the nucleic acid based gene therapy market growth? SWOT analysis of the nucleic acid based gene therapy market.

For detailed insights on the key dynamics influencing the nucleic acid based gene therapy market growth and SWOT analysis of the nucleic acid based gene therapy industry, request a sample here.